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Abstract
Objective—We examined biological motion perception in Parkinson’s disease (PD). Biological 
motion perception is related to one’s own motor function and depends on the integrity of brain 
areas affected in PD, including posterior superior temporal sulcus. If deficits in biological motion 
perception exist, they may be specific to perceiving natural/fast walking patterns that individuals 
with PD can no longer perform, and may correlate with disease-related motor dysfunction.
Method—26 non-demented individuals with PD and 24 control participants viewed videos of 
point-light walkers and scrambled versions that served as foils, and indicated whether each video 
depicted a human walking. Point-light walkers varied by gait type (natural, parkinsonian) and 
speed (0.5, 1.0, 1.5 m/s). Participants also completed control tasks (object motion, coherent motion 
perception), a contrast sensitivity assessment, and a walking assessment.
Results—The PD group demonstrated significantly less sensitivity to biological motion than the 
control group (p<.001, Cohen’s d=1.22), regardless of stimulus gait type or speed, with a less 
substantial deficit in object motion perception (p=.02, Cohen’s d=.68). There was no group 
difference in coherent motion perception. Although individuals with PD had slower walking speed 
and shorter stride length than control participants, gait parameters did not correlate with biological 
motion perception. Contrast sensitivity and coherent motion perception also did not correlate with 
biological motion perception.
Conclusion—PD leads to a deficit in perceiving biological motion, which is independent of gait 
dysfunction and low-level vision changes, and may therefore arise from difficulty perceptually 
integrating form and motion cues in posterior superior temporal sulcus.
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Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative disease that affects visual 
perception and the ability to carry out vision-based activities of daily living (Davidsdottir, 
Cronin-Golomb, & Lee, 2005; Seichepine et al., 2011). With respect to basic motion 
perception, which depends on regions such as the middle temporal area (MT) and the 
temporo-parieto-occipital junction (Andersen, 1997; Grossman et al., 2000; Sunaert, Van 
Hecke, Marchal, & Orban, 1999), some studies have found deficits in PD relative to control 
participants (Trick, Kaskie, & Steinman, 1994), whereas others have found no difference 
(Amick, Cronin-Golomb, & Gilmore, 2003). A more consistent observation is that PD 
impairs higher-level motion perception, such as the perception of motion-defined objects 
including squares and spheres (Uc et al., 2005), motion-defined surfaces (Castelo-Branco et 
al., 2009), and second-order motion (Ezzati, Khadjevand, Zandvakili, & Abbassian, 2010). 
These findings suggest PD-related alterations in extrastriate cortex that mediates visual 
motion perception (Putcha et al., 2014).
One form of motion perception that has not been studied in PD to date is the perception of 
human movement, or biological motion. Biological motion perception is an important cue to 
others’ actions, identity, personality, communicative intent, and emotional state (Atkinson, 
Dittrich, Gemmell, & Young, 2004; Clarke, Bradshaw, Field, Hampson, & Rose, 2005; 
Cutting & Kozlowski, 1977; Dittrich, 1993; Heberlein, Adolphs, Tranel, & Damasio, 2004). 
Even when visual motion cues are isolated to the motion of a set of point-lights on the major 
joints of the body (known as point-light walkers or PLWs), observers readily perceive a 
human. Observers robustly perceive biological motion even when PLW stimuli are presented 
for very brief durations, and when obscured by a mask (Blake & Shiffrar, 2007; Chang & 
Troje, 2009; Cutting, Moore, & Morrison, 1988; Johansson, 1973).
Sensitivity to biological motion may be reduced in PD because of disease-related motor 
deficits. There is strong evidence that action perception and action production are intricately 
connected (“perception-action coupling”) and that the motor system partially mediates 
action perception by simulating or embodying observed actions (Gallese, Gernsbacher, 
Heyes, Hickok, & Iacoboni, 2011; Iacoboni et al., 2005; Shiffrar, 2011). Activity in the 
ventral premotor cortex, part of the mirror neuron network that activates both when 
perceiving and producing actions, predicts individual performance on biological motion 
tasks (Gilaie-Dotan, Kanai, Bahrami, Rees, & Saygin, 2013). Clinical disorders that affect 
motor function including Asperger’s syndrome, paraplegia, and hemiplegia have all been 
associated with reduced sensitivity to biological motion (Arrighi, Cartocci, & Burr, 2011; 
Price, Shiffrar, & Kerns, 2012; Serino et al., 2009). These findings suggest that in PD, motor 
dysfunction may affect visual perception (e.g., Dayan, Inzelberg, & Flash, 2012). There may 
be specific difficulty in perceiving biological motion that individuals with the disease can no 
longer perform (e.g., fast, healthy walking patterns) with relatively spared perception of 
motion that is similar to their own motor ability (e.g., slow, shuffling walking patterns). 
While previous studies have found associations between motor function and biological 
motion perception in other clinical populations (e.g., between unsteadiness and perception of 
PLW stimuli in Asperger’s syndrome; Price et al., 2012), the present study is the first to 
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specifically examine the association between gait characteristics and perception of walking 
from biological motion.
A second reason that biological motion perception may be impaired in PD is because of 
alterations in basic, low-level visual abilities such as contrast sensitivity and coherent motion 
perception. Reduced contrast sensitivity, which is a common finding in PD (Bodis-Wollner 
et al., 1987), would presumably make biological motion cues less salient and more difficult 
to perceive. Alternatively or additionally, a deficit in biological motion perception could be 
explained by reduced sensitivity to low-level coherent motion, or by reduced sensitivity to 
motion-defined forms more generally. The contribution of coherent motion seems less likely 
given mixed findings in PD, whereas difficulty perceiving motion-defined forms is more 
consistently observed and may therefore play a role in biological motion perception.
A third possibility is that deficient biological motion perception in PD may result directly 
from changes specifically to the posterior superior temporal sulcus (STS), which is a 
polysensory region that integrates motion and form cues and is consistently associated with 
biological motion perception in healthy observers (Carter, Hodgins, & Rakison, 2011; 
Grossman, Battelli, & Pascual-Leone, 2005). This possibility was raised by a study that 
found that reduced perception of emotional gestures in PD was associated with decreased 
functional activity in the STS (Lotze et al., 2008). There is also evidence for a visual 
corticostriatal loop connecting the tail of the caudate to extrastriate visual cortex, including 
posterior STS (Seger, 2013), which may be dysfunctional in PD. If biological motion 
perception is impaired in PD, but the deficit is independent of changes in gait and in basic 
vision/motion perception, then extrastriate regions such as the STS may be the more likely 
source of the dysfunction.
The STS is part of a distributed network of brain regions associated with social perception. 
Deficits in social perception are well documented in PD, including difficulties in the 
perception of facial emotions, theory of mind, and processing of verbal and nonverbal social 
cues (Buxton, MacDonald, & Tippett, 2013; Clark, Neargarder, & Cronin-Golomb, 2008, 
2010; Freedman & Stuss, 2011; Pell et al., 2014). There is evidence that sensitivity to 
biological motion is associated with social cognition (Miller & Saygin, 2013), suggesting 
that a possible biological motion perception impairment may be part of a broader 
impairment in social perception and cognition in PD.
The goals and hypotheses of the present study are as follows. The first goal was to determine 
whether non-demented individuals with PD are impaired in perceiving biological motion. 
We predicted that the PD group would perform more poorly on a biological motion 
recognition task than would control participants, but that performance would be relatively 
intact on tasks of object motion and coherent motion perception. The second goal was to 
determine correlates of biological motion perception in PD. In line with evidence of 
perception-action coupling, we hypothesized that individuals with PD would be specifically 
impaired at perceiving biological motion outside their motor repertoire (i.e., fast, natural 
walking patterns), and that objectively measured gait characteristics in PD would correlate 
with performance on the biological motion perception task. We predicted that the 
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hypothesized biological motion perception deficit in PD would be independent of contrast 
sensitivity and coherent motion perception.
Method
Participants
The study included 26 non-demented individuals with PD and 24 healthy control 
participants. The sample size was determined by a power analysis with power = 80%, a 
medium effect size (0.30), and alpha = .05. Participants (PD and control) were recruited 
through the Parkinson’s Disease and Movement Disorders Clinic at Boston Medical Center, 
Boston University’s Sargent College of Health and Rehabilitation Sciences, the Michael J. 
Fox Foundation Trial Finder, and other community sources. PD and control participants 
were matched for age, education, and male:female ratio. All were native speakers of English 
or completed high school in English, had at least 12 years of education, and lived at home 
rather than in an institution. Individuals with PD met clinical criteria for mild to moderate 
idiopathic PD (Hoehn & Yahr Stage 1-3). Motor disability was quantified using the Unified 
Parkinson’s Disease Rating Scale motor subscale. All but one individual with PD were 
taking medications for their motor symptoms and were in the “on” state during testing. 
Levodopa equivalent dosage (LED; mg/day) was calculated for each individual with PD 
using a standardized formula (Tomlinson et al., 2010). Table 1 displays demographic and 
clinical characteristics of the PD group and control group.
Exclusion criteria included serious chronic medical, neurological (other than PD), or 
psychiatric illness; mental retardation; history of intracranial surgery; history of traumatic 
brain injury with loss of consciousness greater than a few seconds; current or previous 
substance or alcohol abuse; and diagnosis of eye disease such as significant current macular 
degeneration, cataract, or glaucoma. Use of antidepressants and anxiolytics was permitted in 
the PD group only, because of the frequent use of these medications in this population. Use 
of such medications in the control group, or other psychoactive medications in either group, 
was grounds for exclusion.
Procedure
All procedures were approved by the Boston University Institutional Review Board in 
accordance with the Declaration of Helsinki. Participants were explained the study 
procedures prior to participating and signed an informed consent form.
Screening Measures and Questionnaires—Dementia was screened by using the 
Columbia-Modified Mini Mental State Examination and all participants scored above 27/30. 
Individuals with PD and control participants were administered the Geriatric Depression 
Scale and the Beck Anxiety Inventory to assess symptoms of depression and anxiety, 
respectively.
Basic Vision and Motion Perception Assessment—Visual acuity was assessed 
using the Lighthouse Near Visual Acuity Test at a distance of 16 inches (40 cm). Participants 
had corrected binocular visual acuity equal to or greater than 20/40 (logarithm mean angle 
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of resolution, log mean angle of resolution ≤ 0.3). Contrast sensitivity was determined using 
the Functional Acuity Contrast Test at a distance of 16 inches (40 cm). This test provides 
contrast sensitivity values for five spatial frequencies (1.5, 3, 6, 12, and 18 cycles per 
degree). These values were used in correlation analyses to determine the relation between 
contrast sensitivity and biological motion perception.
To assess basic, low-level coherent motion perception, a random-dot kinematogram task was 
used. Stimuli were created in which a subset of dots moved either leftward or rightward 
(signal), while additional dots moved in random directions across the screen (noise). The 
following signal to noise ratios were used: 3, 6, 12, 24, 48 and 96%. For each signal-to-noise 
ratio, eight trials were presented in which the dots moved directly left and eight in which 
they moved directly right, for a total of 96 trials. Each stimulus was shown for 500 msec. 
Participants reported verbally whether the subset of coherent dots was moving leftward or 
rightward. A perception threshold was calculated by fitting each participant’s data to a 
Weibull function , where y is the proportion of correct responses, x is the 
proportion signal to noise, and a and b are two curve-fitting parameters. The Weibull 
function is a psychometric function used to model data from two-alternative forced-choice 
paradigms and estimate the signal to noise ratio (coherence level) that corresponds to 
participant performance (i.e., estimate the perception threshold). We computed the percent 
coherence that corresponded to 80% correct performance.
Biological Motion Perception Assessment—Biological motion perception was tested 
using PLW stimuli; the procedures for stimulus creation are described in detail elsewhere 
(Kaiser, Delmolino, Tanaka, & Shiffrar, 2010; Kaiser, Shiffrar, & Pelphrey, 2012; Thomas & 
Shiffrar, 2010). One male and one female adult actor each walked on a treadmill in a 
ReActor motion capture system (Ascension Technology Corporation, Milton, VT). Each 
actor wore 13 sensors attached to the head, shoulders, elbows, and wrists, hips, knees, and 
feet.
In one condition (“Natural”), the actors were instructed to walk as they normally would at 
three different speeds (0.5, 1.0, 1.5 m/s). In a second condition (“Parkinsonian”), the actors 
were instructed to walk like someone with PD: i.e., with short, shuffling steps, decreased 
arm swing, and a forward postural lean. One actor had extensive experience working with 
adults with PD, and the other actor was coached on how to approximate a parkinsonian gait 
pattern. With the parkinsonian gait, both actors walked at the same three speeds (0.5, 1.0, 1.5 
m/s). These PLW stimuli were shown to eight observers (lab members) who had extensive 
experience conducting cognitive and motor assessments with individuals with PD in the lab 
and regularly observed parkinsonian gait. Observers were asked to rate how parkinsonian the 
gait appeared in each stimulus on a 1—5 Likert scale (1 = least parkinsonian; 5 = most 
parkinsonian). The observers’ perceptual ratings confirmed that slower speeds with 
parkinsonian gait were perceived as more parkinsonian, while faster speeds with normal gait 
were perceived as least parkinsonian (mean ratings provided in Table 2). Inter-observer 
reliability was high (intraclass correlation coefficient = .912).
Jaywant et al. Page 5
Neuropsychology. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The purpose of these manipulations of gait and speed was to create two sets of walking 
patterns, one normal and one abnormal (abnormal being similar to parkinsonian walking), to 
test the hypothesis that the PD group would be better at perceiving abnormal, slow walking 
than perceiving fast, healthy walking patterns presumably outside their motor repertoire. 
Each actor walked in one direction only during motion capture. While rendering the movies, 
these PLW stimuli were flipped to create an equal number of walking trials in the opposite 
direction. All PLW stimuli were five seconds in duration to ensure sufficient time for 
participants to perceive and process full strides and inter-limb coordination patterns.
This procedure created a set of 24 “coherent” PLW stimuli (2 actors × 2 directions × 3 
speeds × 2 gait types). For each coherent stimulus, a “scrambled” PLW stimulus was created 
by randomizing the starting location of individual point-lights on the body; this procedure 
ensured the same local dot motions in the scrambled stimuli, but destroyed the spatio-
temporal coherence required to perceive a human walking. The scrambled stimuli served as 
foils in a two-alternative forced choice detection task. The 48 stimuli (24 coherent and 24 
scrambled) were each presented twice for a total of 96 trials. Participants verbally reported 
whether or not they perceived a human walking (“yes” or “no”) and the examiner recorded 
the response. Eight practice trials were conducted using additional stimuli, prior to the 
experimental trials. The dependent variable was an unbiased measure of sensitivity, d’, 
calculated using the standardized hit rate minus the standardized false alarm rate. Hit rates 
and false alarm rates were collapsed across actors and directions.
In a second biological motion perception task, coherent and scrambled PLW stimuli were 
presented in visual noise masks. Following Thomas and Shiffrar (2010), masks were created 
by duplicating each point-light and randomizing its starting location within a one to five 
point radius of one of the points defining the original walker (e.g., the “head dot” could be 
duplicated and positioned near the “right wrist dot”). This procedure was repeated for all 48 
PLW stimuli, creating a corpus in which half of the stimuli were coherent+masked and half 
were scrambled+masked. This masking procedure creates a more challenging 
psychophysical task, which renders the local motions of individual dots uninformative and 
therefore requires the participant to detect the global spatiotemporal structure of the human 
form. Examples of stimuli are provided in Figure 1. Participants completed a two-alternative 
forced choice detection task using coherent-masked and scrambled-masked stimuli that were 
each presented twice (total of 96 trials). They were instructed to decide whether or not they 
perceived a human walking “within a cloud of extra dots.” Participants responded verbally 
(“yes” or “no”) and responses were recorded by the examiner. Eight practice trials were 
conducted using additional stimuli, prior to the experimental trials. The main outcome 
measure was d’. Hit rates and false alarm rates were collapsed across actors and directions.
Object Motion Perception Assessment—This task served as a control condition in 
order to stringently test whether potential perceptual deficits were specific to aspects of 
biological motion because object motion mirrors biological motion in its complexity (i.e., 
animate, non-rigid, jointed), but is non-biological. Object motion perception invokes neural 
substrates that differ from those invoked by biological motion perception (Beauchamp, Lee, 
Haxby, & Martin, 2003). Following Kaiser et al. (2010), the object was a “John Deere 
Loader” toy tractor (Peg Perego, 124.5 × 63.5 cm) filmed as it moved on a treadmill. 13 
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sensors were attached to the tractor (4 on each wheel, 3 on the bucket and bucket pivot joint, 
1 on the top, and 1 at the back). The tractor moved on the treadmill at 1.0 m/s in one 
direction only and the motion capture system was used to create a point-light stimulus of the 
moving tractor. Stimulus construction was analogous to that for the biological motion 
perception task in several respects. While rendering the movie, the point-light object 
stimulus was flipped to create a stimulus moving in the opposite direction. The stimuli were 
five seconds in duration. For each coherent point-light object stimulus, a scrambled point-
light object stimulus was created by randomizing the starting location of each dot, analogous 
to the procedure described above. Participants viewed 20 stimuli (2 moving directions × 2 
stimuli type [coherent/scrambled] × 5 repetitions of each) and had to decide whether or not 
they perceived a moving tractor. Answers were given verbally (“yes” or “no”) and d’ was the 
dependent variable, collapsed across the two moving directions. Participants completed four 
practice trials prior to the experimental trials.
In a second object motion perception task, coherent and scrambled stimuli were presented in 
visual noise masks. The masking procedure was analogous to that for the biological motion 
perception task (i.e., 13 additional dots, duplicated from the original stimulus with a 
randomized starting position). Participants again viewed 20 stimuli (2 moving directions × 2 
stimuli type (coherent/scrambled) × 5 repetitions of each) and reported verbally (“yes” or 
“no”) whether or not they perceived a moving tractor. The outcome measure was d’. 
Participants completed four practice trials prior to the experimental trials.
Administration of screening measures, questionnaires, and vision tests was completed in a 
quiet testing room. The motion perception experiments used a CRT monitor (Mitsubishi 
Diamond Pro 21 inch monitor with 160 Hz max refresh rate) at a distance of 60 cm. All 
stimuli were presented with MatLab 2009a (MathWorks, Natick, MA) and Psychophysics 
Toolbox version 3.0 (Brainard, 1997; Kleiner, Brainard, & Pelli, 2007; Pelli, 1997). 
Participants sat in a comfortable, adjustable seat and were given frequent breaks as needed.
Gait Assessment—All participants completed a gait assessment in the laboratory to 
determine whether gait characteristics were associated with biological motion perception. 
Spatiotemporal gait parameters were derived using tri-axial Geneactiv accelerometers 
(ActivInsights Ltd., Cambridgeshire, UK) at a sampling frequency of 100 Hz (dynamic 
range: +/− 8g; resolution: 12 bit [3.9 mg]). Participants wore the accelerometer on the right 
ankle while walking in a straight line down a hallway. One participant wore the 
accelerometer on the left ankle because the signal was not discernable from the right ankle. 
Participants completed four walking trials: two trials walking for 10m each, and two trials 
walking for 20m each, with different distances to provide diversity in walking to better 
approximate naturalistic settings. All participants were instructed to walk at their natural, 
comfortable walking pace.
Acceleration data was extracted using EMG Works software (Delsys Inc., Natick, MA) and 
temporal gait parameters were based on automatic peak detection functions of the software 
which identified maximal (heel-strike) and secondary (toe-off) peaks from the x-axis of the 
accelerometer, which was oriented in the sagittal plane of the lower limb. This procedure is 
similar to previous methods that have validated accelerometer-measured heel-strikes and 
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toe-offs using footswitches and force plates (Boutaayamou et al., 2012; Heiden & Burnett, 
2004; Lee, Cho, Lee, Yang, & Lee, 2010; Willemsen, Bloemhof, & Boom, 1990).
At the end of each trial, once participants had reached a yellow tape marker that specified 
the end of the walking trial, they often took extra steps past the marker to maintain their 
standing posture and to turn and face the examiner for the subsequent trial. To ensure that we 
did not include these additional steps past the specified endpoint, we first inspected the heel-
strike amplitudes of five consecutive strides from the middle of the trial. We then excluded 
any strides at the end of the trial where the amplitude of the heel-strike was less than 33% of 
the amplitude of the strides in the middle of the trial.
One stride was defined as the time between successive heel strikes of the same leg. The 
spatiotemporal walking variables that were identified included: stride length (distance of 
walking trial / number of strides); stride frequency (number of strides / time to complete the 
walking trial); and walking speed (distance of the walking trial / time to complete the trial). 
For each participant, all spatiotemporal walking variables were calculated separately for the 
four walking trials and then averaged together to determine the mean and standard deviation 
(variability) across the four trials.
Statistical Analyses
Group differences on the motion perception tasks were analyzed using mixed design 
ANOVA with Group (PD, control) as the between-subjects variable and the relevant within-
subjects variables (e.g., Mask Condition [Mask, No Mask]; PLW Speed [0.5, 1.0, 1.5 m/s]; 
PLW Gait Type [parkinsonian, natural]). Statistical tests were two-tailed with alpha of .05. 
Post-hoc comparisons for main and interaction effects were conducted using t-tests. We 
report 95% confidence intervals (in square brackets) whenever appropriate.
For simple main effects and interaction effects in ANOVA, we report effect size using eta-
squared (η2), the proportion of the total variability in the data that is accounted for by that 
effect. For post-hoc comparisons of two means, we report effect size using Cohen’s d, 
where .2 is a small effect, .5 is a medium effect, and .8 is a large effect. The pooled standard 
deviation was used as the standardizer (denominator) for calculating Cohen’s d.
To determine whether biological motion perception was associated with gait parameters or 
visual function, Pearson correlations (two-tailed) were conducted. To account for the large 
number of correlation analyses, we used a conservative alpha level of .01.
Results
Demographics and Clinical Measures
A series of one-way ANOVAs was conducted to examine group differences on demographic 
and clinical measures. As shown in Table 1, there were no significant group differences in 
age, education, general cognitive status, depression, or anxiety (all F’s < 3.68, p’s > .05). 
There was no difference in male:female ratio between groups (χ2 = .35, p = .56) and there 
were no gender × group interactions on any perception tests (all F’s < 1.96, p’s > .05).
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Assessment of Basic Vision and Coherent Motion Perception
The PD and control groups did not differ in visual acuity (F(1,48) = 2.43, p = .13, η2 = .05). 
Group differences in contrast sensitivity (FACT chart) were determined using a 2×5 mixed 
design ANOVA with a between subjects factor of Group (PD, control) and within subjects 
factor of spatial frequency (1.5, 3, 6, 12, and 18 cycles/degree). There was a main effect of 
spatial frequency (F(4,180) = 237.83, p < .001, η2 = .84) and a main effect of Group 
(F(1,45) = 5.8, p = .02, η2 = .11). Individuals with PD had poorer contrast sensitivity than 
control participants regardless of spatial frequency (Mean difference = .11 [.02, .20], p = .02, 
d = .7). There was no Group × spatial frequency interaction (F(4,180) = 1.27, p = .28, η2 = .
004).
On the coherent motion perception task, one individual with PD and one control participant 
were excluded from the analysis because it appeared that they did not understand the task 
and performed at chance level at all coherence levels. An additional three individuals with 
PD were excluded because their threshold values were greater than two standard deviations 
from the group mean. There was no group difference in coherent motion perception 
threshold (mean difference = .34 [−3.37, 4.04], t(43) = .18, p = .86, d = .06).
Biological Motion Perception Task—Overall Performance by Mask Condition
The outcome measure, d’, was calculated using the hit rate and false alarm rate across all 
trials (i.e., collapsed across all stimulus speeds and gaits). As shown in Figure 2, results 
demonstrated a significant main effect of Group (F(1,48) = 19.4, p < .001, η2 = .29), a 
significant main effect of Mask Condition (F(1,48) = 247.56, p < .001, η2 = .82), and a 
significant Group × Mask Condition interaction (F(1,48) = 6.03, p = .02, η2 = .02). Post-hoc 
t-tests revealed that individuals with PD had poorer sensitivity to biological motion than 
control participants in both the No Mask (mean difference = .35 [.08, .62], t(34) = 2.59, p = .
01, d = .72) and Mask conditions (mean difference = .85 [.45, 1.25], t(48) = 4.32, p < .001, d 
= 1.22), though the effect size was much larger in the Mask condition. For both groups, 
masked stimuli rendered the task more difficult as sensitivity to biological motion was lower 
in the Mask than the No Mask condition (mean difference in the PD group = 1.86 [1.54, 
2.18], t(25) = 12.04, p < .001, d = 3.09; mean difference in the control group = 1.36 [1.09, 
1.63], t(23) = 10.33, p < .001, d = 2.61).
Biological Motion Perception Task—Effect of PLW Gait Type
We conducted a three-way (Group × Mask Condition × PLW Gait Type) ANOVA. The 
outcome measure, d’, was calculated using the hit rate and false alarm rate separately for 
natural gait and parkinsonian gait (i.e., collapsed across PLW Speeds). The three-way Group 
× Mask Condition × PLW Gait Type interaction was not significant (F(1,48) = 1.39, p > .05, 
η2 = 001). The analysis revealed a significant Group × Mask Condition interaction (F(1,48) 
= 10.26, p < .01, η2 = .03) and a significant Mask Condition × PLW Gait Type interaction 
(F(1,48) = 65.92, p < .001, η2 = 04). Regardless of PLW Gait Type, the PD group had lower 
sensitivity to biological motion than the control group in the No Mask condition (mean 
difference = .26 [.06, .47], t(31) = 2.68, p = .01, d = .75) and in the Mask condition (Figure 
3; mean difference = .82 [.46, 1.18], t(48) = 4.6, p < .001, d = 1.3). Sensitivity to biological 
motion was lower in the Mask condition than in the No Mask condition for the PD group 
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(mean difference = 1.5 [1.21, 1.78], t(25) = 10.91, p < .001, d = 2.46) and for the control 
group (mean difference = .94 [.73, 1.15], t(23) = 9.21, p < .001, d = 2.50). Across all 
participants, sensitivity to biological motion was greater when viewing PLWs with a 
Parkinsonian gait than with a Natural gait in the Mask condition (mean difference = .71 [.
54, .88], t(49) = 8.42, p < .001, d = 1.02), but there was no difference in the No Mask 
condition (mean difference = .06 [−.03, .16], t(49) = 1.33, p > .05, d = .15).
Biological Motion Perception Task—Effect of PLW Speed
We conducted a three-way (Group × Mask Condition × PLW Speed) ANOVA. The outcome 
measure, d’, was calculated using the hit rate and false alarm rate separately for the three 
PLW speeds (i.e., collapsed across PLW Gait Types). The three-way Group × Mask 
Condition × PLW Speed interaction was not significant (F(2,96) = .08, p > .05, η2 < .001). 
The analysis revealed a significant Group × Mask Condition interaction (F(1,48) = 10.86, p 
< .01, η2 = .03) and a significant Mask Condition × PLW Speed interaction (F(2,96) = 
59.75, p < .001, η2 = .11). Regardless of PLW Speed, the PD group had lower sensitivity to 
biological motion than the control group in the No Mask condition (mean difference = .21 [.
04, .37], t(30) = 2.72, p = .01, d = .76) and in the Mask condition (Figure 4; mean difference 
= .72 [.38, 1.06], t(48) = 4.31, p < .001, d = 1.23). Sensitivity to biological motion was lower 
in the Mask condition than in the No Mask condition for the PD group (mean difference = 
1.26 [1.00, 1.53], t(25) = 9.91, p < .001, d = 2.22) and for the control group (mean difference 
= .75 [.58, .93], t(23) = 8.88, p < .001, d = 2.42).
Across all participants, in the No Mask condition, sensitivity to PLWs at 1.5 m/s was greater 
than at 0.5 m/s (mean difference = .15 [.04, .26], t(49) = 2.65, p = .01, d = .39), and greater 
for 1 m/s than 0.5 m/s (mean difference = .12 [.00, .25], t(49) = 2.02, p <..05, d = .3). There 
was no difference in performance for PLWs moving at 1.5 vs. 1.0 m/s (mean difference = .03 
[−.06, .11], t(49) = .60, p > .05, d = .09). Across all participants, in the Mask condition, 
sensitivity to biological motion was greater for PLWs moving at 1.5 m/s than at 1.0 m/s 
(mean difference = 1.24 [1.05, 1.42], t(49) = 13.38, p < .001, d = 1.88) and 0.5 m/s (mean 
difference = .62 [.44, .81], t(49) = 6.75 p < .001, d = .83). Sensitivity to biological motion 
was poorer at 1 m/s than at 0.5 m/s (mean difference = .62 [.38, .86], t(49) = 5.16, p < .001, 
d = .80).
Object Motion Perception Task
As shown in Figure 5, there was a significant main effect of Group (F(1,48) = 4.34, p = .04, 
η2 = .08), a significant main effect of Mask Condition (F(1,48) = 15.6, p < .001, η2 = .23), 
and a significant Group × Mask Condition interaction (F(1,48) = 4.42, p = .04, η2 = .07). 
Post-hoc t-tests revealed that individuals with PD did not differ from control participants in 
the No Mask condition (mean difference = .09 [−.11, 28], t(48) = .90, p = .37, d = .26), 
whereas in the Mask condition, individuals with PD had significantly lower sensitivity to 
object motion than control participants (mean difference = .38 [.06, .71], t(47) = 2.39, p = .
02, d = .68). Within-group comparisons of performance on the No Mask vs. Mask condition 
showed no difference for control participants (mean difference = .13 [−.1, .36], t(23) = 1.17, 
p = .26, d = .28), but significantly poorer performance in the PD group in the Mask than the 
No Mask condition (mean difference = .43 [.25, .61], t(25) = 4.86, p < .001, d = .91).
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Direct Comparison of Perception Tasks
To compare performance of the PD group across perception tasks, we computed z scores for 
each individual with PD using the mean and standard deviation of the control group, 
separately for the biological motion perception task (Mask condition), object motion 
perception task (Mask condition), and coherent motion perception task. Individuals with PD 
had significantly lower z scores (more impairment) on the biological motion perception task 
(mean z score = −1.23, SD = 1.08) compared to the object motion perception task (mean z 
score = −0.75, SD = 1.21; t(25) = 2.29, p = .031) and the coherent motion perception task 
(mean z score = .05, SD = .95; t(21) = 4.83, p < .001).
Gait and Visual Correlates of Biological Motion Perception
Table 3 displays values for gait parameters in PD and control participants. Compared to the 
control group, the PD group had significantly slower walking speed (F(1,48) = 25.45, p < .
001, η2 = .35) and shorter stride length (F(1,48) = 17.05, p < .001, η2 = .26). There were no 
group differences in stride frequency, or in the variability (standard deviation) of walking 
speed, stride length, and stride frequency (all F’s < 2.76, all p’s > .05, all η2 < .05). In 
neither group were there any significant correlations between mean or standard deviation of 
gait parameters and sensitivity to biological motion perception, in either the No Mask or the 
Mask condition (all r’s < .45, all p’s > .01).
In determining whether contrast sensitivity was associated with biological motion 
perception, one participant with PD was excluded whose contrast sensitivity at 1.5 cpd was 
4.5 standard deviations below the group mean. In the control group, No Mask condition, the 
only significant correlations appeared between contrast sensitivity at 1.5 cycles/degree and 
d’ for PLW stimuli moving at 1.0 m/s (r = .52, p = .01) and between contrast sensitivity at 12 
cycles/degree and d’ for PLW stimuli moving at 1.0 m/s (r = .54, p = .01). There were no 
significant correlations in the Mask condition. In the PD group, no significant correlations 
emerged between contrast sensitivity and sensitivity to biological motion in the No Mask 
and Mask conditions (all r’s < .38, all p’s > .01). We also found no significant correlations 
between coherent motion perception and biological motion perception in either the No Mask 
or Mask conditions, in either group (all r’s < .3, all p’s > .05). Together, these results suggest 
that contrast sensitivity and coherent motion perception did not account for the PD group’s 
reduced sensitivity to biological motion.
Discussion
The main goal of the present study was to determine whether biological motion perception is 
impaired in PD without dementia. In accord with our hypothesis, the results showed less 
sensitivity to biological motion in the PD group than in the matched healthy control group. 
This group difference emerged regardless of whether the PLW stimuli were presented with 
or without a visual noise mask but, as expected, the deficit was more extreme under the 
visual mask condition (large effect) than under the no-mask condition (medium effect size). 
These results demonstrate that PD is associated with a deficit in extracting the global 
spatiotemporal features of human motion under suboptimal viewing conditions, as may 
occur in the natural environment.
Jaywant et al. Page 11
Neuropsychology. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The PD group also showed less sensitivity to object (non-biological) motion than control 
participants, though only when the object was presented in a noise mask. This finding 
suggests that those with PD may have a generalized deficit in perceiving motion-defined 
forms, which is consistent with prior reports of PD-related alterations in perception of 
motion-defined objects (Uc et al., 2005), motion-defined surfaces (Castelo-Branco et al., 
2009), and second-order motion (Ezzati et al., 2010). Individuals with PD, however, 
performed significantly worse on the biological motion task than the object motion task. 
Moreover, the standardized group difference in biological motion perception (large effect 
size) was almost twice that of the group difference in object motion perception (medium 
effect size), indicating that in PD, the magnitude of the deficit is larger for human motion 
than object motion.
In healthy adults, perception of biological motion and object motion activates overlapping 
regions in occipital, parietal, and temporal cortices (Virji-Babul, Cheung, Weeks, Kerns, & 
Shiffrar, 2007), as well as regions that are unique to each type of motion perception. Within 
the lateral temporal cortex, biological motion consistently activates the STS and superior 
temporal gyrus, whereas object motion is associated with activity in middle temporal gyrus 
and inferior temporal sulcus (Beauchamp, Lee, Haxby, & Martin, 2002; Beauchamp et al., 
2003). Our results suggest that in PD, activity in superior temporal regions may be more 
compromised than activity in middle and inferior temporal regions, possibly arising from 
dysfunctional connections between the caudate and extrastriate cortex (Seger, 2013), or 
structural and functional changes to these regions (Lotze et al., 2008; Pereira et al., 2009).
The second goal of this study was to examine gait and visual correlates of biological motion 
perception in PD. We predicted that the PD group would have particular difficulty in 
perceiving biological motion outside their motor repertoire. Contrary to our hypothesis, 
individuals with PD did not have poorer sensitivity to PLW stimuli moving at fast speeds 
compared to slow speeds, or to PLW stimuli with a natural gait compared to a parkinsonian 
gait. These findings were surprising given evidence of specific impairments in perceiving 
motion that patients can no longer perform themselves in other motor disorders (Arrighi et 
al., 2011; Serino et al., 2009), and previous findings that have demonstrated impaired 
perception-action coupling in PD (Poliakoff, Galpin, Dick, Moore, & Tipper, 2007; 
Tremblay, Léonard, & Tremblay, 2008).
One limitation of our approach of using PLW stimuli with parkinsonian gait was that the 
stimuli were actors imitating a parkinsonian gait, which may not have effectively activated 
the mirror neuron system of PD participants. A second limitation is that the noise mask may 
not have adequately masked the parkinsonian PLW stimuli (e.g., due to the lack of 
movement of the dots), given that all participants had increased sensitivity to parkinsonian 
PLW stimuli compared to natural PLW stimuli. To further investigate the perception-action 
association, we calculated spatiotemporal gait parameters (mean and standard deviation 
walking speed, stride length, and stride frequency). Although the PD group had significantly 
slower walking speed and shorter stride length than the control group, there was no 
association between these gait characteristics and biological motion perception in either 
group, providing further evidence against an association between gait deficits in PD and 
biological motion perception.
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Our findings argue against deficient perception-action coupling as the underlying 
mechanism of altered human motion perception in PD. The biological motion deficit was not 
associated with walking dysfunction, and the deficit did not appear to be tied to difficulty 
simulating or embodying actions (mediated by premotor cortex and the mirror neuron 
system) outside the PD group’s motor repertoire. Rather, impaired biological motion 
perception, and to a lesser extent object motion perception, may arise from perceptual 
difficulty in the spatiotemporal integration of form and motion cues, an ability largely 
dependent on posterior STS (biological motion) and middle temporal cortex (object motion). 
Deficient perception-action coupling as it relates to human motion perception may become 
more apparent at later disease stages in PD that are characterized by greater motor 
impairment.
Our results extend previous findings on impaired social perception in PD (Clark et al., 2008, 
2010; Pell et al., 2014), and suggest that the disease results in a broad impairment in social 
processing. Given the relation between biological motion perception and “higher order” 
social cognition such as theory of mind (Miller & Saygin, 2013), reduced sensitivity to 
biological motion may contribute to other observed social difficulties in the disease.
In the present study, biological motion perception was not associated with contrast 
sensitivity, despite the PD group having poorer contrast sensitivity than healthy control 
participants. We assessed contrast sensitivity using the Functional Acuity Contrast Test, 
which is coarser than a threshold measure, and it is possible that contrast sensitivity 
measured in a more sensitive psychophysical test may demonstrate an association with 
biological motion perception in PD. Biological motion perception was also not associated 
with low-level coherent motion perception mediated by area MT, as there were no group 
differences in perception threshold on a coherent motion perception task, nor did these 
thresholds correlate with performance on the biological motion task. These findings provide 
additional support that insensitivity to biological motion in PD is independent of motor and 
basic, low-level perceptual changes.
The possibility exists that the observed deficit in biological motion perception can be 
explained by poor visual attention or reduced processing speed, which occur commonly in 
PD (Jokinen et al., 2013; Zhou et al., 2012). Attention has been shown to play a role in 
action recognition from biological motion, particularly in noisy conditions (Thompson & 
Parasuraman, 2012). It is unlikely that attention was a major contributor to our findings, 
however. First, the biological motion and object motion tasks had an equal number of signal 
and noise dots (i.e., equal attentional demands), but PD participants performed worse on the 
biological motion task. Second, point-light stimuli were presented for 5 seconds to ensure 
participants had sufficient time to attend to and process each stimulus. Finally, PD 
participants were not impaired on the coherent motion task, which was presumably the most 
attentionally demanding as stimuli were presented for only 0.5 seconds with many more 
noise dots than the biological motion and object motion tasks.
In summary, the present study demonstrated that non-demented individuals with PD are 
impaired relative to control participants in perceiving biological motion (large effect), and 
also in perceiving object motion (medium effect). The impairment is significantly worse for 
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biological motion than for object motion. Reduced sensitivity to biological motion in PD 
may arise from changes in STS and lateral middle temporal cortex, rather than from 
deficiencies in perception-action coupling or in lower-level visual perception. Of clinical 
relevance, difficulties in perceiving the movements and actions of others, though 
independent of the severity of individuals’ own gait dysfunction, may lead to difficulty in 
interpersonal communication and social functioning for those living with the disease.
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Figure 1. Static images of point-light walker videos by condition
A. human walker with no mask; B. scrambled walker with no mask; C. human walker in a 
noise mask; and D. scrambled walker in a noise mask.
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Figure 2. Sensitivity to biological motion by Mask Condition and Group
Error bars represent 95% confidence intervals.
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Figure 3. Sensitivity to biological motion by PLW Gait Type (Natural, Parkinsonian) and Group 
in the Mask condition
Error bars represent 95% confidence intervals.
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Figure 4. Sensitivity to biological motion by PLW Speed (0.5, 1.0, 1.5 m/s) and Group in the 
Mask condition
Error bars represent 95% confidence intervals.
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Figure 5. Sensitivity to object motion by Mask Condition and Group
Error bars represent 95% confidence intervals.
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